AUPH logo

Aurinia Pharmaceuticals Inc. (AUPH) Free Cash Flow

Annual FCF:

$44.11M+$78.29M(+229.05%)
December 31, 2024

Summary

  • As of today, AUPH annual free cash flow is $44.11 million, with the most recent change of +$78.29 million (+229.05%) on December 31, 2024.
  • During the last 3 years, AUPH annual free cash flow has risen by +$203.30 million (+127.71%).
  • AUPH annual free cash flow is now at all-time high.

Performance

AUPH Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHcash flow metrics

Quarterly FCF:

$44.92M-$50.90K(-0.11%)
September 30, 2025

Summary

  • As of today, AUPH quarterly free cash flow is $44.92 million, with the most recent change of -$50.90 thousand (-0.11%) on September 30, 2025.
  • Over the past year, AUPH quarterly free cash flow has increased by +$28.10 million (+166.99%).
  • AUPH quarterly free cash flow is now -0.11% below its all-time high of $44.97 million, reached on June 30, 2025.

Performance

AUPH Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHcash flow metrics

TTM FCF:

$120.39M+$28.10M(+30.44%)
September 30, 2025

Summary

  • As of today, AUPH TTM free cash flow is $120.39 million, with the most recent change of +$28.10 million (+30.44%) on September 30, 2025.
  • Over the past year, AUPH TTM free cash flow has increased by +$91.67 million (+319.24%).
  • AUPH TTM free cash flow is now at all-time high.

Performance

AUPH TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

AUPH Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+229.1%+167.0%+319.2%
3Y3 Years+127.7%+418.4%+205.4%
5Y5 Years+169.3%+230.5%+215.1%

AUPH Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+127.7%-0.1%+239.6%at high+205.4%
5Y5-Yearat high+127.7%-0.1%+182.1%at high+176.0%
All-TimeAll-Timeat high+127.7%-0.1%+182.1%at high+176.0%

AUPH Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2025
-
$44.92M(-0.1%)
$120.39M(+30.4%)
Jun 2025
-
$44.97M(+3405.2%)
$92.29M(+46.4%)
Mar 2025
-
$1.28M(-95.6%)
$63.06M(+46.1%)
Dec 2024
$44.11M(+229.0%)
$29.21M(+73.6%)
$43.16M(+50.3%)
Sep 2024
-
$16.83M(+6.9%)
$28.72M(+2169.4%)
Jun 2024
-
$15.74M(+184.6%)
-$1.39M(+93.2%)
Mar 2024
-
-$18.61M(-226.0%)
-$20.30M(+40.1%)
Dec 2023
-$34.18M(+57.2%)
$14.77M(+211.2%)
-$33.87M(+7.6%)
Sep 2023
-
-$13.28M(-317.9%)
-$36.64M(+2.2%)
Jun 2023
-
-$3.18M(+90.1%)
-$37.47M(+39.5%)
Mar 2023
-
-$32.18M(-368.2%)
-$61.90M(+19.1%)
Dec 2022
-$79.82M(+49.9%)
$12.00M(+185.1%)
-$76.54M(+33.0%)
Sep 2022
-
-$14.11M(+48.9%)
-$114.22M(+17.5%)
Jun 2022
-
-$27.61M(+41.0%)
-$138.39M(+8.0%)
Mar 2022
-
-$46.83M(-82.3%)
-$150.43M(+5.0%)
Dec 2021
-$159.19M(-106.2%)
-$25.68M(+32.9%)
-$158.33M(-19.2%)
Sep 2021
-
-$38.28M(+3.5%)
-$132.83M(-3.0%)
Jun 2021
-
-$39.64M(+27.6%)
-$128.97M(-15.8%)
Mar 2021
-
-$54.72M(>-9900.0%)
-$111.37M(-40.1%)
Dec 2020
-$77.20M(-21.2%)
-$188.60K(+99.5%)
-$79.47M(+24.1%)
Sep 2020
-
-$34.41M(-56.1%)
-$104.63M(-27.0%)
Jun 2020
-
-$22.04M(+3.4%)
-$82.39M(-12.0%)
Mar 2020
-
-$22.82M(+10.0%)
-$73.54M(-15.1%)
Dec 2019
-$63.69M(-23.2%)
-$25.35M(-108.2%)
-$63.89M(-23.3%)
Sep 2019
-
-$12.18M(+7.7%)
-$51.80M(-2.3%)
Jun 2019
-
-$13.19M(-0.2%)
-$50.63M(-2.3%)
Mar 2019
-
-$13.17M(+0.7%)
-$49.49M(+2.4%)
Dec 2018
-$51.69M(-25.5%)
-$13.26M(-20.5%)
-$50.73M(-5.5%)
Sep 2018
-
-$11.01M(+8.6%)
-$48.07M(-2.1%)
Jun 2018
-
-$12.05M(+16.3%)
-$47.10M(-0.8%)
Mar 2018
-
-$14.40M(-35.8%)
-$46.74M(-11.1%)
Dec 2017
-$41.19M(-119.8%)
-$10.61M(-5.6%)
-$42.06M(-19.0%)
Sep 2017
-
-$10.04M(+14.1%)
-$35.35M(-20.2%)
Jun 2017
-
-$11.69M(-20.3%)
-$29.41M(-27.3%)
Mar 2017
-
-$9.72M(-149.5%)
-$23.10M(-24.2%)
Dec 2016
-$18.74M(-5.2%)
-$3.90M(+5.2%)
-$18.61M(+4.0%)
Sep 2016
-
-$4.11M(+23.6%)
-$19.39M(+2.5%)
Jun 2016
-
-$5.38M(-3.0%)
-$19.88M(-8.9%)
Mar 2016
-
-$5.22M(-11.6%)
-$18.26M(-7.0%)
Dec 2015
-$17.82M(-12.8%)
-$4.68M(-1.5%)
-$17.07M(-11.6%)
Sep 2015
-
-$4.61M(-22.7%)
-$15.29M(-3.6%)
Jun 2015
-
-$3.75M(+6.9%)
-$14.76M(+2.8%)
Mar 2015
-
-$4.03M(-39.0%)
-$15.19M(+0.8%)
Dec 2014
-$15.80M(-255.5%)
-$2.90M(+28.8%)
-$15.32M(-4.0%)
Sep 2014
-
-$4.08M(+2.6%)
-$14.72M(-20.6%)
Jun 2014
-
-$4.18M(-0.6%)
-$12.21M(-45.4%)
Mar 2014
-
-$4.16M(-80.2%)
-$8.39M(-88.9%)
Dec 2013
-$4.44M(+32.2%)
-$2.31M(-48.1%)
-$4.44M(-47.3%)
Sep 2013
-
-$1.56M(-319.9%)
-$3.02M(-14.4%)
Jun 2013
-
-$371.00K(-79.2%)
-$2.63M(+47.3%)
Mar 2013
-
-$207.00K(+76.5%)
-$5.00M(+24.3%)
Dec 2012
-$6.55M
-$879.50K(+25.3%)
-$6.61M(+5.3%)
Sep 2012
-
-$1.18M(+57.0%)
-$6.98M(+0.7%)
DateAnnualQuarterlyTTM
Jun 2012
-
-$2.74M(-51.1%)
-$7.03M(-21.4%)
Mar 2012
-
-$1.81M(-44.8%)
-$5.79M(-131.7%)
Dec 2011
-$2.59M(+42.9%)
-$1.25M(-1.9%)
-$2.50M(-25.0%)
Sep 2011
-
-$1.23M(+18.1%)
-$2.00M(+11.8%)
Jun 2011
-
-$1.50M(-201.3%)
-$2.27M(-29.7%)
Mar 2011
-
$1.48M(+296.7%)
-$1.75M(+62.1%)
Dec 2010
-$4.53M(+53.8%)
-$752.40K(+49.7%)
-$4.61M(+16.1%)
Sep 2010
-
-$1.50M(-52.6%)
-$5.49M(-1.2%)
Jun 2010
-
-$980.10K(+29.2%)
-$5.43M(+36.8%)
Mar 2010
-
-$1.38M(+15.4%)
-$8.60M(+17.9%)
Dec 2009
-$9.81M(+51.5%)
-$1.64M(-14.2%)
-$10.47M(-3.1%)
Sep 2009
-
-$1.43M(+65.4%)
-$10.15M(+6.7%)
Jun 2009
-
-$4.15M(-27.4%)
-$10.88M(-1.2%)
Mar 2009
-
-$3.25M(-147.0%)
-$10.75M(+39.2%)
Dec 2008
-$20.22M(+25.3%)
-$1.32M(+39.0%)
-$17.68M(+26.5%)
Sep 2008
-
-$2.16M(+46.3%)
-$24.06M(+21.8%)
Jun 2008
-
-$4.02M(+60.6%)
-$30.77M(+7.6%)
Mar 2008
-
-$10.19M(-32.5%)
-$33.31M(-14.2%)
Dec 2007
-$27.06M(-18.3%)
-$7.69M(+13.4%)
-$29.17M(-5.6%)
Sep 2007
-
-$8.88M(-35.3%)
-$27.61M(-16.8%)
Jun 2007
-
-$6.56M(-8.5%)
-$23.65M(-8.2%)
Mar 2007
-
-$6.04M(+1.5%)
-$21.85M(+2.3%)
Dec 2006
-$22.87M(-8.6%)
-$6.13M(-24.8%)
-$22.36M(-2.0%)
Sep 2006
-
-$4.91M(-3.2%)
-$21.93M(-9.4%)
Jun 2006
-
-$4.76M(+27.3%)
-$20.05M(+5.1%)
Mar 2006
-
-$6.56M(-15.1%)
-$21.13M(+1.1%)
Dec 2005
-$21.05M(-5.1%)
-$5.70M(-87.5%)
-$21.35M(+7.9%)
Sep 2005
-
-$3.04M(+48.0%)
-$23.19M(+10.2%)
Jun 2005
-
-$5.84M(+13.9%)
-$25.83M(-5.8%)
Mar 2005
-
-$6.78M(+10.0%)
-$24.40M(-17.9%)
Dec 2004
-$20.02M(-178.5%)
-$7.54M(-32.9%)
-$20.70M(-43.2%)
Sep 2004
-
-$5.67M(-28.6%)
-$14.46M(-11.7%)
Jun 2004
-
-$4.41M(-42.9%)
-$12.94M(-100.7%)
Mar 2004
-
-$3.09M(-139.1%)
-$6.45M(+11.5%)
Dec 2003
-$7.19M(-21.2%)
-$1.29M(+68.9%)
-$7.29M(+32.7%)
Sep 2003
-
-$4.16M(-299.6%)
-$10.82M(-176.2%)
Jun 2003
-
$2.08M(+153.1%)
-$3.92M(+32.0%)
Mar 2003
-
-$3.92M(+18.8%)
-$5.76M(-5.0%)
Dec 2002
-$5.93M(+31.1%)
-$4.83M(-275.6%)
-$5.49M(-76.7%)
Sep 2002
-
$2.75M(+1065.9%)
-$3.11M(+46.3%)
Jun 2002
-
$235.80K(+106.5%)
-$5.78M(+34.2%)
Mar 2002
-
-$3.65M(-49.2%)
-$8.78M(-8.8%)
Dec 2001
-$8.61M(-27.2%)
-
-
Dec 2001
-
-$2.44M(-3471.9%)
-$8.08M(-43.4%)
Sep 2001
-
$72.50K(+102.6%)
-$5.63M(+1.3%)
Jun 2001
-
-$2.77M(+5.9%)
-$5.71M(-94.1%)
Mar 2001
-
-$2.94M(-401.6%)
-$2.94M(-113.9%)
Dec 2000
-$6.77M(-350.1%)
-
-
Nov 1999
-$1.50M(+28.8%)
-$586.10K(-575.2%)
-$1.37M(-74.3%)
Aug 1999
-
-$86.80K(+88.3%)
-$788.40K(-12.4%)
May 1999
-
-$739.00K(-2075.9%)
-$701.60K(-1975.9%)
Feb 1999
-
$37.40K
$37.40K
Nov 1998
-$2.11M
-
-

FAQ

  • What is Aurinia Pharmaceuticals Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for Aurinia Pharmaceuticals Inc.?
  • What is Aurinia Pharmaceuticals Inc. annual free cash flow year-on-year change?
  • What is Aurinia Pharmaceuticals Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for Aurinia Pharmaceuticals Inc.?
  • What is Aurinia Pharmaceuticals Inc. quarterly free cash flow year-on-year change?
  • What is Aurinia Pharmaceuticals Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for Aurinia Pharmaceuticals Inc.?
  • What is Aurinia Pharmaceuticals Inc. TTM free cash flow year-on-year change?

What is Aurinia Pharmaceuticals Inc. annual free cash flow?

The current annual free cash flow of AUPH is $44.11M

What is the all-time high annual free cash flow for Aurinia Pharmaceuticals Inc.?

Aurinia Pharmaceuticals Inc. all-time high annual free cash flow is $44.11M

What is Aurinia Pharmaceuticals Inc. annual free cash flow year-on-year change?

Over the past year, AUPH annual free cash flow has changed by +$78.29M (+229.05%)

What is Aurinia Pharmaceuticals Inc. quarterly free cash flow?

The current quarterly free cash flow of AUPH is $44.92M

What is the all-time high quarterly free cash flow for Aurinia Pharmaceuticals Inc.?

Aurinia Pharmaceuticals Inc. all-time high quarterly free cash flow is $44.97M

What is Aurinia Pharmaceuticals Inc. quarterly free cash flow year-on-year change?

Over the past year, AUPH quarterly free cash flow has changed by +$28.10M (+166.99%)

What is Aurinia Pharmaceuticals Inc. TTM free cash flow?

The current TTM free cash flow of AUPH is $120.39M

What is the all-time high TTM free cash flow for Aurinia Pharmaceuticals Inc.?

Aurinia Pharmaceuticals Inc. all-time high TTM free cash flow is $120.39M

What is Aurinia Pharmaceuticals Inc. TTM free cash flow year-on-year change?

Over the past year, AUPH TTM free cash flow has changed by +$91.67M (+319.24%)
On this page